Innospec Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.6% | +1.1% | -13.0% | +1.9% | +5.3% | -5.6% | -0.2% | +0.5% | +3.1% | -0.5% | +8.4% | – | |
| – | +3.7% | +1.6% | -10.6% | +3.6% | +3.5% | -4.5% | +0.3% | +2.7% | +0.9% | +0.5% | +7.1% | – | |
| – | +13.5% | +0.0% | -18.5% | -2.2% | +9.8% | -8.1% | -1.5% | -5.3% | +9.2% | -3.1% | +12.0% | – | |
| – | -23.3% | +57.3% | +0.0% | -20.7% | +14.4% | +0.0% | +7.1% | +0.7% | -19.7% | +20.0% | +7.6% | – | |
| – | +24.9% | -13.2% | -19.1% | -9.3% | +250.1% | -69.5% | +7.5% | -3.6% | -3.6% | +13.3% | +7.4% | – | |
| – | +16.7% | -5.4% | -18.1% | -8.9% | +21.1% | -13.1% | +7.6% | -3.7% | -6.2% | +14.2% | +7.5% | – | |
| – | +6.2% | +13.5% | -19.4% | +12.0% | -9.9% | +3.4% | -19.3% | -9.3% | +51.4% | -32.5% | +24.8% | – | |
| – | +12.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.6% | +22.1% | -21.0% | +2.5% | -329.0% | – | -28.2% | -63.9% | +337.4% | -20.7% | +4.3% | – | |
| – | -9.6% | +85.3% | -10.1% | -8.8% | -382.5% | – | -27.6% | -116.7% | – | +213.8% | +14.3% | – | |
| – | -3.6% | +9.5% | -24.6% | +7.1% | -310.8% | – | -28.4% | -45.1% | +267.4% | -35.9% | +1.3% | – | |
| – | +3.5% | +14.1% | -17.2% | +12.6% | -18.1% | +11.6% | -14.5% | -49.2% | +155.1% | -16.6% | -22.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.